{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:06:54Z","timestamp":1793149614476,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Projects Coordination Unit, Hacettepe University","award":["TSA-2016-7276"],"award-info":[{"award-number":["TSA-2016-7276"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hypocholesterolemia is the most frequently encountered lipid abnormality in sickle cell disease (SCD). We enrolled pediatric patients to determine the relationships between lipid profile and parameters of hemolysis, oxidative stress and chronic inflammation in SCD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study involved 35 pediatric SCD patients and 19 healthy controls. Patients were crisis-free and had not received transfusions for the last 3\u00a0months. Total cholesterol, triglyceride, HDL-C, LDL-C, VLDL-C, apolipoprotein A1, apolipoprotein B, LCAT, LDH, bilirubin, haptoglobin, iron, ferritin, hemin, serum amyloid A (SAA), myeloperoxidase (MPO), uric acid, ALT and GGT levels were evaluated in patients\u2019 blood.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Patients had hypocholesterolemia depicted by lower levels of total cholesterol, HDL-C, LDL-C, as well as Apolipoprotein A1 and Apolipoprotein B compared to controls. The chronic hemolysis of SCD was evident in patients by higher LDH and bilirubin and almost undetectable haptoglobin levels. Hemin levels (as a measure of oxidized heme) were significantly increased in patients with SCD. Inflammation markers, SAA and MPO, were significantly increased in the patients as well. There were negative correlations between HDL-C and LDH, and Apo A1 and SAA. Hemin was positively correlated to MPO.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Hemolysis was associated with decreased HDL \u2013C, and Inflammation was linked to decreased apolipoprotein A1 levels in our SCD patients. Therefore, we suggest that the HDL particle is altered during the course of the disease. The altered HDL in SCD may become dysfunctional and result with a slowing down of the reverse cholesterol transport.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12944-019-1174-5","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T11:02:44Z","timestamp":1576839764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation"],"prefix":"10.1186","volume":"18","author":[{"given":"Ahmet","family":"Yalcinkaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-9744","authenticated-orcid":false,"given":"Yesim","family":"Oztas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. Sickle cell disease. Nat Rev Dis Prim. 2018;4:18010.","journal-title":"Nat Rev Dis Prim"},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10245332.2018.1498441","volume":"24","author":"S Biswal","year":"2019","unstructured":"Biswal S, Rizwan H, Pal S, Sabnam S, Parida P, Pal A. Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children. Hematology. 2019;24:1\u20139.","journal-title":"Hematology"},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127:750\u201360.","journal-title":"J Clin Invest"},{"key":"1174_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2003-08-2760","volume":"104","author":"ML Jison","year":"2004","unstructured":"Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C, Raghavachari N, Beigel JH, Shelhamer JH, Danner RL, Gladwin MT. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood. 2004;104:270\u201380.","journal-title":"Blood"},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1476-511X-9-91","volume":"9","author":"MO Seixas","year":"2010","unstructured":"Seixas MO, Rocha LC, Carvalho MB, Menezes JF, Lyra IM, Nascimento VM, Couto RD, Atta AM, Reis MG, Goncalves MS. Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease. Lipids Health Dis. 2010;9:91.","journal-title":"Lipids Health Dis"},{"key":"1174_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12944-018-0689-5","volume":"17","author":"ML Lalanne-Mistrih","year":"2018","unstructured":"Lalanne-Mistrih ML, Connes P, Lamarre Y, Lemonne N, Hardy-Dessources MD, Tarer V, Etienne-Julan M, Mougenel D, Tressieres B, Romana M. Lipid profiles in French West Indies sickle cell disease cohorts, and their general population. Lipids Health Dis. 2018;17:38.","journal-title":"Lipids Health Dis"},{"key":"1174_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajh.20804","volume":"82","author":"H Shalev","year":"2007","unstructured":"Shalev H, Kapelushnik J, Moser A, Knobler H, Tamary H. Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol. 2007;82:199\u2013202.","journal-title":"Am J Hematol"},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10238-010-0124-3","volume":"11","author":"YE Oztas","year":"2011","unstructured":"Oztas YE, Sabuncuoglu S, Unal S, Ozgunes H, Ozgunes N. Hypocholesterolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients. Clin Exp Med. 2011;11:195\u20138.","journal-title":"Clin Exp Med"},{"key":"1174_CR9","unstructured":"Yal\u00e7\u0131nkaya A, Lay \u0130, Samadi A, \u00dcnal S, Akb\u0131y\u0131k F, \u00d6zta\u015f Y. Hypocholesterolemia and increased plasma 7-ketocholesterol levels in pediatric sickle cell patients. Acta Medica. 2017:1\u20134."},{"key":"1174_CR10","doi-asserted-by":"crossref","unstructured":"Yalcinkaya A, Samadi A, Lay I, Unal S, Sabuncuoglu S, Oztas Y. Oxysterol concentrations are associated with cholesterol concentrations and anemia in pediatric patients with sickle cell disease. Scand J Clin Lab Invest. 2019:1\u20137.","DOI":"10.1080\/00365513.2019.1627578"},{"key":"1174_CR11","doi-asserted-by":"publisher","first-page":"E321","DOI":"10.1152\/ajpendo.00324.2012","volume":"304","author":"NE Miller","year":"2013","unstructured":"Miller NE, Olszewski WL, Hattori H, Miller IP, Kujiraoka T, Oka T, Iwasaki T, Nanjee MN. Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid. Am J Phys Endocrinol Metab. 2013;304:E321\u20138.","journal-title":"Am J Phys Endocrinol Metab"},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2141.2010.08109.x","volume":"149","author":"S Zorca","year":"2010","unstructured":"Zorca S, Freeman L, Hildesheim M, Allen D, Remaley AT, Taylor JG, Kato GJ. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol. 2010;149:436\u201345.","journal-title":"Br J Haematol"},{"key":"1174_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cmet.2005.03.005","volume":"1","author":"DJ Rader","year":"2005","unstructured":"Rader DJ, Pur\u00e9 E. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab. 2005;1:223\u201330.","journal-title":"Cell Metab"},{"key":"1174_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1194\/jlr.E900001-JLR200","volume":"50","author":"B Shao","year":"2009","unstructured":"Shao B, Heinecke JW. HDL, lipid peroxidation, and atherosclerosis. J Lipid Res. 2009;50:599\u2013601.","journal-title":"J Lipid Res"},{"key":"1174_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/13506120802525210","volume":"15","author":"C Li","year":"2008","unstructured":"Li C, Kisilevsky R. Serum amyloid A, in vivo splenic cholesterol export and its potential implications in hemolytic disorders. Amyloid. 2008;15:246\u201354.","journal-title":"Amyloid"},{"key":"1174_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3324\/haematol.2009.018044","volume":"95","author":"A Tumblin","year":"2010","unstructured":"Tumblin A, Tailor A, Hoehn GT, Mack AK, Mendelsohn L, Freeman L, Xu X, Remaley AT, Munson PJ, Suffredini AF, Kato GJ. Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica. 2010;95:1467\u201372.","journal-title":"Haematologica"},{"key":"1174_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4103\/0300-1652.140388","volume":"55","author":"KS Akinlade","year":"2014","unstructured":"Akinlade KS, Adewale CO, Rahamon SK, Fasola FA, Olaniyi JA, Atere AD. Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis. Niger Med J. 2014;55:428\u201331.","journal-title":"Niger Med J"},{"key":"1174_CR18","first-page":"183","volume":"70","author":"E Mokondjimobe","year":"2012","unstructured":"Mokondjimobe E, Longo-Mbenza B, Ovono-Abessolo F, Gombet T, Guie G, Ngou-Milama E, Parra HJ. Lipid, lipoproteins and atherogenesis profiles in sickle cell disease among Central African patients. Ann Biol Clin (Paris). 2012;70:183\u20138.","journal-title":"Ann Biol Clin (Paris)"},{"key":"1174_CR19","unstructured":"Oztas Y, Unal S, Gumus L, Eskandari G, Ozgunes N. Altered levels of serum lipids in sickle cell disease suggest a metabolic or structural alteration of the lipoprotein particles. In IFCC WorldLab Istanbul, vol. 52. p. 1179. Clin Chem Lab Med. 2014:1179."},{"key":"1174_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/17584299.4.1.113","volume":"4","author":"MG Sorci-Thomas","year":"2009","unstructured":"Sorci-Thomas MG, Bhat S, Thomas MJ. Activation of lecithin: cholesterol acyltransferase by HDL ApoA-I central helices. Clin Lipidol. 2009;4:113\u201324.","journal-title":"Clin Lipidol"},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11745-013-3849-4","volume":"48","author":"OH Ozturk","year":"2013","unstructured":"Ozturk OH, Can Y, Yonden Z, Motor S, Oktay G, Kaya H, Aslan M. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients. Lipids. 2013;48:1217\u201326.","journal-title":"Lipids"},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1177\/1535370216657447","volume":"241","author":"E Soupene","year":"2016","unstructured":"Soupene E, Borja MS, Borda M, Larkin SK, Kuypers FA. Featured article: alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood. Exp Biol Med (Maywood). 2016;241:1933\u201342.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood.V114.22.259.259","volume":"114","author":"JJ Strouse","year":"2009","unstructured":"Strouse JJ, Kraut M, Williams LM, DeBaun MR, Casella JF. Low levels of apolipoprotein A1 are associated with silent cerebral infarcts in children with sickle cell disease. Blood. 2009;114:259.","journal-title":"Blood"},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12011-009-8534-3","volume":"136","author":"JI Anetor","year":"2010","unstructured":"Anetor JI, Ajose OA, Adeleke FN, Olaniyan-Taylor GO, Fasola FA. Depressed antioxidant status in pregnant women on iron supplements: pathologic and clinical correlates. Biol Trace Elem Res. 2010;136:157\u201370.","journal-title":"Biol Trace Elem Res"},{"key":"1174_CR25","doi-asserted-by":"publisher","first-page":"11158","DOI":"10.1021\/bi7006349","volume":"46","author":"A Salvatore","year":"2007","unstructured":"Salvatore A, Cigliano L, Bucci EM, Corpillo D, Velasco S, Carlucci A, Pedone C, Abrescia P. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry. 2007;46:11158\u201368.","journal-title":"Biochemistry"},{"key":"1174_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1071576031000060607","volume":"37","author":"N Phumala","year":"2003","unstructured":"Phumala N, Porasuphatana S, Unchern S, Pootrakul P, Fucharoen S, Chantharaksri U. Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia\/hemoglobin E disease. Free Radic Res. 2003;37:129\u201335.","journal-title":"Free Radic Res"},{"key":"1174_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1182\/blood.V126.23.975.975","volume":"126","author":"MOS Carvalho","year":"2015","unstructured":"Carvalho MOS, Rocha LC, Reis JHO, Santos TA, do Nascimento VML, Carvalho MB, Luz NF, VdM B, Goncalves MS. Heme concentration as a biomarker of sickle cell disease severity: its role in steady-state and in crisis patients. Blood. 2015;126:975.","journal-title":"Blood"},{"key":"1174_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","volume":"121","author":"DJ Schaer","year":"2013","unstructured":"Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121:1276\u201384.","journal-title":"Blood"},{"key":"1174_CR29","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jacl.2018.08.002","volume":"12","author":"F Vendrame","year":"2018","unstructured":"Vendrame F, Olops L, Saad STO, Costa FF, Fertrin KY. Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease. J Clin Lipidol. 2018;12:1532\u20138.","journal-title":"J Clin Lipidol"},{"key":"1174_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/jcp.47.2.166","volume":"47","author":"J Stuart","year":"1994","unstructured":"Stuart J, Stone PC, Akinola NO, Gallimore JR, Pepys MB. Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease. J Clin Pathol. 1994;47:166\u20139.","journal-title":"J Clin Pathol"},{"key":"1174_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0140-6736(93)90418-G","volume":"341","author":"A Singhal","year":"1993","unstructured":"Singhal A, Doherty JF, Raynes JG, McAdam KP, Thomas PW, Serjeant BE, Serjeant GR. Is there an acute-phase response in steady-state sickle cell disease? Lancet. 1993;341:651\u20133.","journal-title":"Lancet"},{"key":"1174_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","volume":"61","author":"KL Bourantas","year":"1998","unstructured":"Bourantas KL, Dalekos GN, Makis A, Chaidos A, Tsiara S, Mavridis A. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol. 1998;61:49\u201354.","journal-title":"Eur J Haematol"},{"key":"1174_CR33","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1194\/jlr.M300133-JLR200","volume":"44","author":"R Kisilevsky","year":"2003","unstructured":"Kisilevsky R, Tam SP. Macrophage cholesterol efflux and the active domains of serum amyloid a 2.1. J Lipid Res. 2003;44:2257\u201369.","journal-title":"J Lipid Res"},{"key":"1174_CR34","first-page":"490","volume":"2012","author":"B Shao","year":"1821","unstructured":"Shao B. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Biochim Biophys Acta. 1821;2012:490\u2013501.","journal-title":"Biochim Biophys Acta"},{"key":"1174_CR35","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1194\/jlr.M038281","volume":"54","author":"H Zhang","year":"2013","unstructured":"Zhang H, Xu H, Weihrauch D, Jones DW, Jing X, Shi Y, Gourlay D, Oldham KT, Hillery CA, Pritchard KA Jr. Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. J Lipid Res. 2013;54:3009\u201315.","journal-title":"J Lipid Res"},{"key":"1174_CR36","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1177\/1535370217706966","volume":"242","author":"E Soupene","year":"2017","unstructured":"Soupene E, Larkin SK, Kuypers FA. Featured article: depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients. Exp Biol Med (Maywood). 2017;242:1244\u201353.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"1174_CR37","doi-asserted-by":"publisher","first-page":"e0164264","DOI":"10.1371\/journal.pone.0164264","volume":"11","author":"Xiang Ji","year":"2016","unstructured":"Ji X, Feng Y, Tian H, Meng W, Wang W, Liu N, Zhang J, Wang L, Wang J, Gao H. The mechanism of proinflammatory HDL generation in sickle cell disease is linked to cell-free hemoglobin via haptoglobin. PLoS One. 2016;11:\u2013e0164264.","journal-title":"PLOS ONE"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1174-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:12:22Z","timestamp":1608336742000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1174-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1174-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from Mersin University Clinical Research Ethical Committee (2014\/115). All patients and controls (and their caretakers) provided written informed consent. All steps of the study conformed to the Helsinki Declaration and Good Clinical Practice guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}